Follow
Mohan Appaiahgari
Mohan Appaiahgari
Srikara Biologicals Private Limited
No verified email
Title
Cited by
Cited by
Year
Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls
MB Appaiahgari, S Vrati
Expert opinion on biological therapy 15 (3), 337-351, 2015
1182015
Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants
MB Appaiahgari, R Glass, S Singh, S Taneja, T Rongsen-Chandola, ...
Vaccine 32 (6), 651-656, 2014
862014
Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis
S Bhowmick, R Duseja, S Das, MB Appaiahgiri, S Vrati, A Basu
Neuroscience letters 414 (1), 45-50, 2007
862007
IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine
MB Appaiahgari, S Vrati
Expert review of vaccines 9 (12), 1371-1384, 2010
822010
A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial
N Bhandari, P Sharma, S Taneja, T Kumar, T Rongsen-Chandola, ...
Journal of Infectious Diseases 200 (3), 421-429, 2009
772009
Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal …
MB Appaiahgari, M Saini, M Rauthan, S Vrati
Microbes and infection 8 (1), 92-104, 2006
652006
DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain
MB Appaiahgari, S Vrati
Molecular Therapy 15 (9), 1593-1599, 2007
612007
Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV)
MB Appaiahgari, S Vrati
Expert opinion on biological therapy 12 (9), 1251-1263, 2012
442012
Japanese encephalitis virus (JEV) is an important cause of encephalitis among children in Cuddalore district, Tamil Nadu, India
L Kabilan, S Vrati, S Ramesh, S Srinivasan, MB Appaiahgari, ...
Journal of clinical virology 31 (2), 153-159, 2004
422004
Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells
MB Appaiahgari, S Vrati
Vaccine 22 (27-28), 3669-3675, 2004
422004
Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines
MB Appaiahgari, RM Pandey, S Vrati
Clinical and Vaccine Immunology 14 (8), 1053-1055, 2007
392007
Effect of cytokine‐encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice
K Bharati, MB Appaiahgari, S Vrati
Microbiology and immunology 49 (4), 349-353, 2005
272005
Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies
M Rauthan, R Kaur, MB Appaiahgari, S Vrati
Microbes and infection 6 (14), 1305-1311, 2004
222004
Expression of Japanese encephalitis virus envelope protein in transgenic tobacco plants
MB Appaiahgari, MZ Abdin, KC Bansal, S Vrati
Journal of virological methods 162 (1-2), 22-29, 2009
172009
Rotavirus Vaccine Development Group. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind …
N Bhandari, P Sharma, S Taneja, T Kumar, T Rongsen-Chandola, ...
J Infect Dis 200 (3), 421-429, 2009
172009
Descriptive epidemiology of rotavirus infection in a community in North India
TR Chandola, S Taneja, N Goyal, SS Rathore, MB Appaiahgari, A Mishra, ...
Epidemiology & Infection 141 (10), 2094-2100, 2013
152013
Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies
R Kulandaisamy, T Kushwaha, A Dalal, V Kumar, D Singh, K Baswal, ...
Frontiers in Microbiology 13, 877813, 2022
102022
Molecular cloning and characterization of Chikungunya virus genes from Indian isolate of 2006 outbreak
S Gupta, S Vrati
J Pharm Res 55, 3860-3863, 2012
102012
Plant-based edible vaccines: issues and advantages
MB Appaiahgari, U Kiran, A Ali, S Vrati, MZ Abdin
Plant biotechnology: principles and applications, 329-366, 2017
52017
Identification of a novel inhibitor of SARS-CoV-2 main protease: an in silico, biochemical, and cell-based approach
A Trivedi, V Kardam, KK Inampudi, S Vrati, D Gupta, A Singh, ...
The FEBS journal 290 (23), 5496-5513, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20